StockNews.AI
MIR
StockNews.AI
215 days

Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024

1. Mirion to release Q4 and FY 2024 results on February 11, 2025. 2. Conference call scheduled for February 12, 2025, at 11:00 am ET. 3. Investors can access results and call via Mirion's investor website. 4. Mirion operates globally in radiation safety and healthcare markets.

6m saved
Insight
Article

FAQ

Why Neutral?

Earnings announcements typically have uncertain effects on stock prices.

How important is it?

Earnings calls are key for performance assessments but past results vary.

Why Short Term?

Immediate investor response expected post-results may influence price temporarily.

Related Companies

Mirion Announces Earnings Release and Conference Call Date for Fourth Quarter and Full Year 2024

ATLANTA--( )--Mirion (NYSE: MIR) announced today that it will release financial results for fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Following the news release, the company will host a conference call the next day, Wednesday, February 12, 2025, at 11:00 am ET to discuss the results.

Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until February 26, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13751221. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

Contacts

Eric Linn
ir@mirion.com

Related News